![Gervais Tougas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gervais Tougas
Direttore/Membro del Consiglio presso
Novartis Europharm Ltd.
Profilo
Gervais Tougas is currently working as a Director at Novartis Europharm Ltd. He previously worked as the Chief Medical Officer & Head-Patient Safety at Novartis AG and as the Chief Medical Officer at Maat Pharma SA from 2023 to 2024.
Posizioni attive di Gervais Tougas
| Società | Posizione | Inizio |
|---|---|---|
Novartis Europharm Ltd.
 Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direttore/Membro del Consiglio | 09/01/2014 |
Precedenti posizioni note di Gervais Tougas
| Società | Posizione | Fine |
|---|---|---|
| MAAT PHARMA | Direttore Tecnico/Scientifico/R&S | 24/06/2024 |
| NOVARTIS AG | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
10
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
